Trial Profile
Open labeled, single arm, multi centered, phase II trial to evaluate the efficacy and safety of combination therapy of rituximab and cladribine for previously untreated patients with advanced staged extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue and nodal marginal zone B-cell lymphoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2012
Price :
$35
*
At a glance
- Drugs Cladribine (Primary) ; Rituximab (Primary)
- Indications Marginal zone B-cell lymphoma
- Focus Therapeutic Use
- 02 Jul 2012 New trial record